AGP Executive Report
Last update: 3 hours agoSopharma’s Stock Surge: Bulgarian pharma Sopharma has overtaken Shelly Group to become the largest listed company on the Bulgarian Stock Exchange, with its market cap up nearly 20% in a month to over €1.24bn, after strong July sales and a 35% jump in first-half net profit. Retail Demand Pulse: Eurostat data show Bulgaria’s retail trade volume rose 5.6% year-on-year in July 2026, placing it fifth in the EU, though growth is slowing versus earlier months. Inflation Outlook: ING lifted its 2026 average inflation forecast for Bulgaria to 5.1% (from 4.9%) and cut 2027 growth to 2.3%, while expecting inflation to ease but remain higher than previously projected. EU Budget Fight: Senior EU officials in Dublin pushed for new “own resources” and taxes to fund the 2028–2034 long-term budget, clashing with scepticism from frugal member states. Nuclear Cooperation: Prime Ministers Rumen Radev and Robert Fico agreed to set up a joint commission with Slovakia to share nuclear know-how and support talks with Westinghouse on new reactors. Security & Energy Risks: Bulgaria reiterated support for Germany over alleged Russian hybrid sabotage tied to explosives-laden drones at Leipzig, while separate reports describe suspected arson and sabotage incidents near defence and power sites, including Bulgarian suspects in Munich cases.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.